Medical Developments International Limited

ASX:MVP Stock Report

Market Cap: AU$45.6m

Medical Developments International Dividends and Buybacks

Dividend criteria checks 0/6

Medical Developments International does not currently pay a dividend.

Key information

0%

Dividend yield

0%

Buyback Yield

Total Shareholder Yield0%
Future Dividend Yieldn/a
Dividend Growthn/a
Next dividend pay daten/a
Ex dividend daten/a
Dividend per shareAU$0.040
Payout ratio0%

Recent dividend and buyback updates

Recent updates

Positive Sentiment Still Eludes Medical Developments International Limited (ASX:MVP) Following 27% Share Price Slump

May 13
Positive Sentiment Still Eludes Medical Developments International Limited (ASX:MVP) Following 27% Share Price Slump

Is Medical Developments International (ASX:MVP) In A Good Position To Invest In Growth?

May 03
Is Medical Developments International (ASX:MVP) In A Good Position To Invest In Growth?

Why Investors Shouldn't Be Surprised By Medical Developments International Limited's (ASX:MVP) 28% Share Price Plunge

Mar 11
Why Investors Shouldn't Be Surprised By Medical Developments International Limited's (ASX:MVP) 28% Share Price Plunge

Medical Developments International Limited (ASX:MVP) Soars 28% But It's A Story Of Risk Vs Reward

Jan 16
Medical Developments International Limited (ASX:MVP) Soars 28% But It's A Story Of Risk Vs Reward

Will Medical Developments International (ASX:MVP) Spend Its Cash Wisely?

Jan 03
Will Medical Developments International (ASX:MVP) Spend Its Cash Wisely?

Is Medical Developments International (ASX:MVP) In A Good Position To Deliver On Growth Plans?

Aug 09
Is Medical Developments International (ASX:MVP) In A Good Position To Deliver On Growth Plans?

We're Keeping An Eye On Medical Developments International's (ASX:MVP) Cash Burn Rate

Apr 24
We're Keeping An Eye On Medical Developments International's (ASX:MVP) Cash Burn Rate

Is Medical Developments International (ASX:MVP) In A Good Position To Deliver On Growth Plans?

Jul 04
Is Medical Developments International (ASX:MVP) In A Good Position To Deliver On Growth Plans?

Some Analysts Just Cut Their Medical Developments International Limited (ASX:MVP) Estimates

Mar 04
Some Analysts Just Cut Their Medical Developments International Limited (ASX:MVP) Estimates

Medical Developments International Limited (ASX:MVP) Analysts Just Slashed This Year's Estimates

Mar 05
Medical Developments International Limited (ASX:MVP) Analysts Just Slashed This Year's Estimates

If You Had Bought Medical Developments International (ASX:MVP) Shares Five Years Ago You'd Have Earned 56% Returns

Feb 07
If You Had Bought Medical Developments International (ASX:MVP) Shares Five Years Ago You'd Have Earned 56% Returns

Don't Ignore The Fact That This Insider Just Sold Some Shares In Medical Developments International Limited (ASX:MVP)

Dec 16
Don't Ignore The Fact That This Insider Just Sold Some Shares In Medical Developments International Limited (ASX:MVP)

Medical Developments International Limited's (ASX:MVP) Has Been On A Rise But Financial Prospects Look Weak: Is The Stock Overpriced?

Dec 10
Medical Developments International Limited's (ASX:MVP) Has Been On A Rise But Financial Prospects Look Weak: Is The Stock Overpriced?

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if MVP's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if MVP's dividend payments have been increasing.


Dividend Yield vs Market

Medical Developments International Dividend Yield vs Market
How does MVP dividend yield compare to the market?
SegmentDividend Yield
Company (MVP)0%
Market Bottom 25% (AU)2.6%
Market Top 25% (AU)6.2%
Industry Average (Pharmaceuticals)2.5%
Analyst forecast (MVP) (up to 3 years)n/a

Notable Dividend: Unable to evaluate MVP's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate MVP's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: MVP is not paying a notable dividend for the Australian market.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as MVP has not reported any payouts.


Discover strong dividend paying companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 19:04
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Medical Developments International Limited is covered by 5 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Dennis HulmeAPP Securities Pty Ltd.
Anubhav SaxenaBell Potter
Martyn JacobsCanaccord Genuity